Poly(ADP-ribose) polymerase: Killer or conspirator? The 'suicide hypothesis' revisited

Trends in Pharmacological Sciences

Volumn 23, Issue 3, 2002, Pages 122-129

  Chiarugi, Alberto ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOBENZAMIDE; ADENOSINE TRIPHOSPHATE; ALPHA CHEMOKINE; ENZYME INHIBITOR; GAMMA INTERFERON; GLYCOSIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE; MULTIDRUG RESISTANCE PROTEIN 1; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1 INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 2; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 3; NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE; NITRIC OXIDE SYNTHASE; PHOSPHATE; POLY(ADENOSINE DIPHOSPHATE RIBOSE)GLYCOHYDROLASE; PROTEIN KINASE C; PROTEIN P53; RIBOSEPHOSPHATE PYROPHOSPHOKINASE; RNA POLYMERASE II; TANKYRASE; TANKYRASE 2; TRANSCRIPTION FACTOR AP 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

CALCIUM MOBILIZATION; CELL DEATH; CELL ENERGY; CELL SURVIVAL; DNA DAMAGE; DNA REPAIR; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; GENETIC TRANSCRIPTION; GENOTOXICITY; HOMEOSTASIS; HUMAN; HYPOTHESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; CELL DEATH; CELLS, CULTURED; DNA DAMAGE; DNA REPAIR; POLY(ADP-RIBOSE) POLYMERASES; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 0036499892     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(00)01902-7     Document Type: Review

References (72)

1. Cellular euthanasia mediated by a nuclear enzyme: A central role for nuclear ADP-ribosylation in cellular metabolism
2. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
3. Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death
4. Poly (ADP-ribose) polymerase-1: What we have learned from the deficient mouse model?
5. Poly (ADP-ribose) in the cellular response to DNA damage
6. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion
7. Poly (ADP-ribose) polymerase, nitric oxide and cell death
8. The world according to PARP
9. Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic β-cell destruction and diabetes development induced by streptozotocin
10. Diabetic endothelial dysfunction: The role of poly(ADP-ribose) polymerase activation
11. Role of poly(ADP-ribose)synthetase in inflammation
12. Resistance to endotoxic shock as a consequence of defective NF-κB activation in poly(ADP-ribose) polymerase-1 deficient mice
13. Protection against the hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase
14. Poly (ADP-ribose) polymerase-1 in the nervous system
15. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion
16. Poly(ADP-ribose)polymerase null mouse cells synthesize ADP-ribose polymers
17. NAD consumption in carcinogen-treated hamster cells overexpressing a dominant negative mutant of poly(ADP-ribose)polymerase
18. Mechanisms of endothelial cell ATP depletion after oxidant injury
19. ATP for the DNA ligation step in base excision repair is generated from poly(ADP-ribose)
20. Overexpression of human poly(ADP-ribose)polymerase in transfected hamster cells leads to increased poly(ADP-ribosyl)ation and cellular sensitization to gamma irradiation
21. Increased resistance to anticancer therapy of mouse cell lacking the poly(ADP-ribose) polymerase attributable to up-regulation of the multidrug resistance gene product P-glycoprotein
22. Effect of transient focal ischemia of mouse brain on energy state and NAD levels: No evidence that NAD depletion plays a major role in secondary disturbances of energy metabolism
23. Inhibition of poly(ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis
24. Characterization of sPARP-1. An alternative product of PARP-1 gene with poly(ADP-ribose) polymerase activity independent of DNA strand breaks
25. PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase
26. A human poly(ADP-ribose) polymerase gene family (ADPRTL): cDNA cloning of two novel poly(ADP-ribose) polymerase homologues
27. Tankyrase promotes telomere elongation in human cells
28. Tankyrase is a Golgi-associated MAP kinase substrate that interacts with IRAP in GLUT4 vesicles
29. Identification of a novel human tankyrase through its interaction with the adaptor protein Grb14
30. TANK2, a new TRF1-associated poly(ADP-ribose) polymerase, causes rapid induction of cell death upon overexpression
31. The 193 kDa vault protein, VPARP, is a novel poly(ADP-ribose)polymerase
32. Poly(ADP-ribosy)ation basally activated by DNA strand breaks reflects glutamate-nitric oxide neurotransmission
33. A fast signal induced activation of poly(ADP-ribose)polymerase: A downstream target of phospholipase C
34. Phosphorylation of poly(ADP-ribose) polymerase protein in human peripheral lymphocytes stimulated with phytohemagglutinin
35. Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase
36. Novel inhibitors of poly(ADP-ribose)polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast
37. A cellular survival switch: Poly(ADP-ribosyl)ation stimulates DNA repair and silences transcription
38. A cellular defense pathway to regulate transcription through poly(ADP-ribosyl)ation in response to DNA damage
39. Association of poly(adenosine diphosphate ribosylated) nucleosomes with transcriptionally active and inactive regions of chromatin
40. Poly(ADP-ribose)polymerase enhances activator-dependent transcription in vitro
41. Involvement of poly(ADP-ribose)-polymerase in the Pax-6 gene regulation in neuroretina
42. Purification and analysis of a factor which suppresses nick-induced transcription by RNA polymerase II and its identity with poly(ADP-ribose) polymerase
43. Poly(ADP-ribose)polymerase is a coactivator for AP2-mediated transcriptional activation
44. Interaction of Oct-1 and automodification domain of poly(ADP-ribose) synthetase
45. A role of poly(ADP-ribose) polymerase in NF-κB transcriptional activation
46. Poly(ADP-ribosyl)ation is required for p53-dependent signal transduction induced by radiation
47. A role for poly(ADP-ribose) polymerase (PARP) in the transcriptional regulation of the melanoma growth stimulatory activity (CXCL1) gene expression
48. Activation of Reg gene, a gene for insulin-producing β-cell regeneration: Poly(ADP-ribose) polymerase binds Reg promoter and regulates the transcription by autopoly(ADP-ribosyl)ation
49. Amelioration of diabetes mellitus in partially depancreatized rats by poly(ADP-ribose) synthetase inhibitors. Evidence of islet B-cell regeneration
50. Poly(ADP-ribose)polymerase binds with transcription enhancer factor 1 to MCAT1 elements to regulate muscle-specific transcription
51. Multiprotein complex formation at the β myosin heavy chain distal muscle CAT element correlates with slow muscle expression but not mechanical overload responsiveness
52. Misregulation of gene expression in primary fibroblasts lacking poly(ADP-ribose) polymerase
53. How NF-κB is activated: The role of the IkB kinase (IKK) complex
54. The Rel/NF-κB family: Friend and foe
55. Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF-κB activation
56. Poly(ADP-ribose) polymerase is involved in PMA-induced activation of HIV-1 in U1 cells by modulating the LTR function
57. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease
58. Involvement of NAD-poly(ADP-ribose) metabolism in p53 regulation and its consequences
59. Defective induction and normal activation and function of p53 in mouse cells lacking poly-ADP-ribose polymerase
60. -/- mice: Genome stabilization in immortalized cells by reintroduction of poly(ADP-ribose)polymerase cDNA
61. Overexpressed poly(ADP-ribose) polymerase delays the release of rat cells from p53-mediated G(1) checkpoint
62. ATM-dependent telomere loss in aging human diploid fibroblast and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose)polymerase
63. Poly(ADP-ribose) binds to specific domain of p53 and alters its DNA binding functions
64. Poly(ADP-ribosyl)ation of p53 during apoptosis in human osteosarcoma cells
65. Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins
66. Roles of Poly(ADP-ribosyl)ation and repair in apoptosis, DNA repair, genomic stability and functions of p53 and E2F-1
67. Compensatory expression of p73 in PARP-deficient mouse fibroblast as response to reduced level of regularly spliced wild-type p53
68. Possible role of NF-κB and p53 in the glutamate-induced pro-apoptotic neuronal pathway
69. Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP1, NF-κB and Myc/Max
70. Nuclear factor κB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum
71. Role of NFκB in p53-mediated programmed cell death
72. Transcriptional cross talk between NF-κB and p53